Schrödinger receives $57M from Lilly's acquisition of co-founded Ajax Therapeutics

Filed June 29, 2026 · Period ending June 29, 2026 · ~1 min read

Key Changes

• high

  Schrödinger received approximately $57 million in cash from Eli Lilly's acquisition of Ajax Therapeutics, a company Schrödinger co-founded, with additional milestone payments possible upon future clinical and regulatory achievements.

  Item 7.01 — Regulation FD Disclosure verify on EDGAR →